Pentacyclic Triterpenes of the Lupane, Oleanane and Ursane Group as Tools in Cancer Therapy

 

 Permissions and Reprints

Abstract

Today cancer treatment is not only a question of eliminating cancer cells by induction of cell death. New therapeutic strategies also include targeting the tumour microenvironment, avoiding angiogenesis, modulating the immune response or the chronic inflammation that is often associated with cancer. Furthermore, the induction of redifferentiation of dedifferentiated cancer cells is an interesting aspect in developing new therapy strategies. Plants provide a broad spectrum of potential drug substances for cancer therapy with multifaceted effects and targets. Pentacyclic triterpenes are one group of promising secondary plant metabolites. This review summarizes the potential of triterpenes belonging to the lupane, oleanane or ursane group, to treat cancer by different modes of action. Since Pisha et al. reported in 1995 that betulinic acid is a highly promising anticancer drug after inducing apoptosis in melanoma cell lines in vitro and in vivo, experimental work focused on the apoptosis inducing mechanisms of betulinic acid and other triterpenes. The antitumour effects were subsequently confirmed in a series of cancer cell lines from other origins, for example breast, colon, lung and neuroblastoma. In addition, in the last decade many studies have shown further effects that justify the expectation that triterpenes are useful to treat cancer by several modes of action. Thus, triterpene acids are known mainly for their antiangiogenic effects as well as their differentiation inducing effects. In particular, lupane-type triterpenes, such as betulin, betulinic acid and lupeol, display anti-inflammatory activities which often accompany immune modulation. Triterpene acids as well as triterpene monoalcohols and diols also show an antioxidative potential. The pharmacological potential of triterpenes of the lupane, oleanane or ursane type for cancer treatment seems high; although up to now no clinical trial has been published using these triterpenes in cancer therapy. They provide a multitarget potential for coping with new cancer strategies. Whether this is an effective approach for cancer treatment has to be proven. Because various triterpenes are an increasingly promising group of plant metabolites, the utilisation of different plants as their sources is of interest. Parts of plants, for example birch bark, rosemary leaves, apple peel and mistletoe shoots are rich in triterpenes and provide different triterpene compositions.

References

• 1 Trosko J E. The role of stem cells and gap junctions as targets for cancer chemoprevention and chemotherapy.  Biomed Pharmacother. 2005;  59 (Suppl. 2) 326-331
  CrossrefPubMedGoogle Scholar
• 2 Brenner D E, Gescher A J. Cancer chemoprevention: lessons learned and future directions.  Br J Cancer. 2005;  93 735-739
  CrossrefPubMedGoogle Scholar
• 3 Xu R, Fazio G C, Matsuda S P. On the origins of triterpenoid skeletal diversity.  Phytochemistry. 2004;  65 261-291
  CrossrefPubMedGoogle Scholar
• 4 Ekman R. The submarin monomers and triterpenoids from the outer bark of Betula verrucosa EHRH.  Holzforschung. 1983;  37 205-211
  CrossrefPubMedGoogle Scholar
• 5 Laszczyk M, Jäger S, Simon-Haarhaus B, Scheffler A, Schempp C M. Physical, chemical and pharmacological characterization of a new oleogel-forming triterpene extract from the outer bark of birch (betulae cortex).  Planta Med. 2006;  72 1389-1395
  Article in Thieme ConnectPubMedGoogle Scholar
• 6 Jäger S, Trojan H, Kopp T, Laszczyk M N, Scheffler A. Pentacyclic triterpene distribution in various plants – rich sources for a new group of multi-potent plant extracts.  Molecules. 2009;  14 2016-2031
  CrossrefPubMedGoogle Scholar
• 7 Chaturvedi P K, Bhui K, Shukla Y. Lupeol: connotations for chemoprevention.  Cancer Lett. 2008;  263 1-13
  CrossrefPubMedGoogle Scholar
• 8 Ovesna Z, Vachalkova A, Horvathova K, Tothova D. Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview.  Neoplasma. 2004;  51 327-333
  PubMedGoogle Scholar
• 9 Fulda S. Betulinic acid: a natural product with anticancer activity.  Mol Nutr Food Res. 2009;  53 140-146
  CrossrefPubMedGoogle Scholar
• 10 Fulda S, Jeremias I, Steiner H H, Pietsch T, Debatin K M. Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells.  Int J Cancer. 1999;  82 435-441
  CrossrefPubMedGoogle Scholar
• 11 Galgon T, Wohlrab W, Dräger B. Betulinic acid induces apoptosis in skin cancer cells and differentiation in normal human keratinocytes.  Exp Dermatol. 2005;  14 736-743
  CrossrefPubMedGoogle Scholar
• 12 Kessler J H, Mullauer F B, de Roo G M, Medema J P. Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types.  Cancer Lett. 2007;  251 132-145
  CrossrefPubMedGoogle Scholar
• 13 Selzer E, Pimentel E, Wacheck V, Schlegel W, Pehamberger H, Jansen B, Kodym R. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells.  J Invest Dermatol. 2000;  114 935-940
  CrossrefPubMedGoogle Scholar
• 14 Zuco V, Supino R, Righetti S C, Cleris L, Marchesi E, Gambacorti-Passerini C, Formelli F. Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells.  Cancer Lett. 2002;  175 17-25
  CrossrefPubMedGoogle Scholar
• 15 Wachsberger P R, Burd R, Wahl M L, Leeper D B. Betulinic acid sensitization of low pH adapted human melanoma cells to hyperthermia.  Int J Hyperthermia. 2002;  18 153-164
  CrossrefPubMedGoogle Scholar
• 16 Noda Y, Kaiya T, Kohda K, Kawazoe Y. Enhanced cytotoxicity of some triterpenes toward leukemia L1210 cells cultured in low pH media: possibility of a new mode of cell killing.  Chem Pharm Bull (Tokyo). 1997;  45 1665-1670
  PubMedGoogle Scholar
• 17 Fulda S, Scaffidi C, Susin S A, Krammer P H, Kroemer G, Peter M E, Debatin K M. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid.  J Biol Chem. 1998;  273 33942-33948
  CrossrefPubMedGoogle Scholar
• 18 Tan Y, Yu R, Pezzuto J M. Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation.  Clin Cancer Res. 2003;  9 2866-2875
  PubMedGoogle Scholar
• 19 Liu W K, Ho J C, Cheung F W, Liu B P, Ye W C, Che C T. Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line.  Eur J Pharmacol. 2004;  498 71-78
  CrossrefPubMedGoogle Scholar
• 20 Martin R, Carvalho J, Ibeas E, Hernandez M, Ruiz-Gutierrez V, Nieto M L. Acidic triterpenes compromise growth and survival of astrocytoma cell lines by regulating reactive oxygen species accumulation.  Cancer Res. 2007;  67 3741-3751
  CrossrefPubMedGoogle Scholar
• 21 Mullauer F B, Kessler J H, Medema J P. Betulinic acid induces cytochrome c release and apoptosis in a Bax/Bak-independent, permeability transition pore dependent fashion.  Apoptosis. 2009;  14 191-202
  CrossrefPubMedGoogle Scholar
• 22 Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nunez G, Krammer P H, Peter M E, Debatin K M. Betulinic acid triggers CD95 (APO-1/Fas)- and p 53-independent apoptosis via activation of caspases in neuroectodermal tumors.  Cancer Res. 1997;  57 4956-4964
  PubMedGoogle Scholar
• 23 Selzer E, Thallinger C, Hoeller C, Oberkleiner P, Wacheck V, Pehamberger H, Jansen B. Betulinic acid-induced Mcl-1 expression in human melanoma–mode of action and functional significance.  Mol Med. 2002;  8 877-884
  PubMedGoogle Scholar
• 24 Wick W, Grimmel C, Wagenknecht B, Dichgans J, Weller M. Betulinic acid-induced apoptosis in glioma cells: a sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing.  J Pharmacol Exp Ther. 1999;  289 1306-1312
  PubMedGoogle Scholar
• 25 Rzeski W, Stepulak A, Szymanski M, Sifringer M, Kaczor J, Wejksza K, Zdzisinska B, Kandefer-Szerszen M. Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells.  Naunyn Schmiedebergs Arch Pharmacol. 2006;  374 11-20
  CrossrefPubMedGoogle Scholar
• 26 Kasperczyk H, La Ferla-Bruhl K, Westhoff M A, Behrend L, Zwacka R M, Debatin K M, Fulda S. Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy.  Oncogene. 2005;  24 6945-6956
  CrossrefPubMedGoogle Scholar
• 27 Rabi T, Shukla S, Gupta S. Betulinic acid suppresses constitutive and TNFalpha-induced NF-kappaB activation and induces apoptosis in human prostate carcinoma PC-3 cells.  Mol Carcinogen. 2008;  47 964-973
  PubMedGoogle Scholar
• 28 Saleem M, Kweon M H, Yun J M, Adhami V M, Khan N, Syed D N, Mukhtar H. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model.  Cancer Res. 2005;  65 11203-11213
  CrossrefPubMedGoogle Scholar
• 29 Murtaza I, Saleem M, Adhami V M, Hafeez B B, Mukhtar H. Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells.  Cancer Res. 2009;  69 1156-1165
  CrossrefPubMedGoogle Scholar
• 30 Saleem M, Kaur S, Kweon M H, Adhami V M, Afaq F, Mukhtar H. Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway.  Carcinogenesis. 2005;  26 1956-1964
  CrossrefPubMedGoogle Scholar
• 31 Manu K A, Kuttan G. Ursolic acid induces apoptosis by activating p 53 and caspase-3 gene expressions and suppressing NF-kappaB mediated activation of bcl-2 in B16F-10 melanoma cells.  Int Immunopharmacol. 2008;  8 974-981
  CrossrefPubMedGoogle Scholar
• 32 Zhang P, Li H, Chen D, Ni J, Kang Y, Wang S. Oleanolic acid induces apoptosis in human leukemia cells through caspase activation and poly(ADP-ribose) polymerase cleavage.  Acta Biochim Biophys Sin (Shanghai). 2007;  39 803-809
  CrossrefPubMedGoogle Scholar
• 33 Kim D S, Pezzuto J M, Pisha E. Synthesis of betulinic acid derivatives with activity against human melanoma.  Bioorg Med Chem Lett. 1998;  8 1707-1712
  CrossrefPubMedGoogle Scholar
• 34 Hata K, Hori K, Ogasawara H, Takahashi S. Anti-leukemia activities of Lup-28-al-20(29)-en-3-one, a lupane triterpene.  Toxicol Lett. 2003;  143 1-7
  CrossrefPubMedGoogle Scholar
• 35 Pyo J S, Roh S H, Kim D K, Lee J G, Lee Y Y, Hong S S, Kwon S W, Park J H. Anti-cancer effect of betulin on a human lung cancer cell line: a pharmacoproteomic approach using 2D SDS PAGE coupled with nano-HPLC tandem mass spectrometry.  Planta Med. 2009;  75 127-131
  Article in Thieme ConnectPubMedGoogle Scholar
• 36 Juan M E, Wenzel U, Daniel H, Planas J M. Erythrodiol, a natural triterpenoid from olives, has antiproliferative and apoptotic activity in HT-29 human adenocarcinoma cells.  Mol Nutr Food Res. 2008;  52 595-599
  CrossrefPubMedGoogle Scholar
• 37 Huyke C, Reuter J, Rodig M, Kersten A, Laszczyk M, Scheffler A, Nashan D, Schempp C. Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study.  J Dtsch Dermatol Ges. 2009;  7 128-133
  PubMedGoogle Scholar
• 38 Sohn K H, Lee H Y, Chung H Y, Young H S, Yi S Y, Kim K W. Anti-angiogenic activity of triterpene acids.  Cancer Lett. 1995;  94 213-218
  CrossrefPubMedGoogle Scholar
• 39 Kiran M S, Viji R I, Sameer Kumar V B, Sudhakaran P R. Modulation of angiogenic factors by ursolic acid.  Biochem Biophys Res Commun. 2008;  371 556-560
  CrossrefPubMedGoogle Scholar
• 40 Cardenas C, Quesada A R, Medina M A. Effects of ursolic acid on different steps of the angiogenic process.  Biochem Biophys Res Commun. 2004;  320 402-408
  CrossrefPubMedGoogle Scholar
• 41 Jedinak A, Muckova M, Kost'alova D, Maliar T, Masterova I. Antiprotease and antimetastatic activity of ursolic acid isolated from Salvia officinalis.  Z Naturforsch [C]. 2006;  61 777-782
  PubMedGoogle Scholar
• 42 Melzig M F, Bormann H. Betulinic acid inhibits aminopeptidase N activity.  Planta Med. 1998;  64 655-657
  Article in Thieme ConnectPubMedGoogle Scholar
• 43 Bauvois B, Dauzonne D. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.  Med Res Rev. 2006;  26 88-130
  CrossrefPubMedGoogle Scholar
• 44 Bhagwat S V, Lahdenranta J, Giordano R, Arap W, Pasqualini R, Shapiro L H. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation.  Blood. 2001;  97 652-659
  CrossrefPubMedGoogle Scholar
• 45 Kwon H J, Shim J S, Kim J H, Cho H Y, Yum Y N, Kim S H, Yu J. Betulinic acid inhibits growth factor-induced in vitro angiogenesis via the modulation of mitochondrial function in endothelial cells.  Jpn J Cancer Res. 2002;  93 417-425
  PubMedGoogle Scholar
• 46 Lee M S, Moon E J, Lee S W, Kim M S, Kim K W, Kim Y J. Angiogenic activity of pyruvic acid in in vivo and in vitro angiogenesis models.  Cancer Res. 2001;  61 3290-3293
  PubMedGoogle Scholar
• 47 Chintharlapalli S, Papineni S, Ramaiah S K, Safe S. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors.  Cancer Res. 2007;  67 2816-2823
  CrossrefPubMedGoogle Scholar
• 48 You Y J, Nam N H, Kim Y, Bae K H, Ahn B Z. Antiangiogenic activity of lupeol from Bombax ceiba.  Phytother Res. 2003;  17 341-344
  CrossrefPubMedGoogle Scholar
• 49 Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation.  Nature. 2008;  454 436-444
  CrossrefPubMedGoogle Scholar
• 50 Ahmad S F, Khan B, Bani S, Suri K A, Satti N K, Qazi G N. Amelioration of adjuvant-induced arthritis by ursolic acid through altered Th1/Th2 cytokine production.  Pharmacol Res. 2006;  53 233-240
  CrossrefPubMedGoogle Scholar
• 51 Altinier G, Sosa S, Aquino R P, Mencherini T, Della Loggia R, Tubaro A. Characterization of topical antiinflammatory compounds in Rosmarinus officinalis L.  J Agric Food Chem. 2007;  55 1718-1723
  CrossrefPubMedGoogle Scholar
• 52 Banno N, Akihisa T, Tokuda H, Yasukawa K, Higashihara H, Ukiya M, Watanabe K, Kimura Y, Hasegawa J, Nishino H. Triterpene acids from the leaves of Perilla frutescens and their anti-inflammatory and antitumor-promoting effects.  Biosci Biotechnol Biochem. 2004;  68 85-90
  CrossrefPubMedGoogle Scholar
• 53 de la Puerta R, Martinez-Dominguez E, Ruiz-Gutierrez V. Effect of minor components of virgin olive oil on topical antiinflammatory assays.  Z Naturforsch [C]. 2000;  55 814-819
  PubMedGoogle Scholar
• 54 Fernandez M A, de las Heras B, Garcia M D, Saenz M T, Villar A. New insights into the mechanism of action of the anti-inflammatory triterpene lupeol.  J Pharm Pharmacol. 2001;  53 1533-1539
  CrossrefPubMedGoogle Scholar
• 55 Miceli N, Taviano M F, Giuffrida D, Trovato A, Tzakou O, Galati E M. Anti-inflammatory activity of extract and fractions from Nepeta sibthorpii Bentham.  J Ethnopharmacol. 2005;  97 261-266
  CrossrefPubMedGoogle Scholar
• 56 Recio M C, Giner R M, Manez S, Gueho J, Julien H R, Hostettmann K, Rios J L. Investigations on the steroidal anti-inflammatory activity of triterpenoids from Diospyros leucomelas.  Planta Med. 1995;  61 9-12
  Article in Thieme ConnectPubMedGoogle Scholar
• 57 Alakurtti S, Makela T, Koskimies S, Yli-Kauhaluoma J. Pharmacological properties of the ubiquitous natural product betulin.  Eur J Pharm Sci. 2006;  29 1-13
  CrossrefPubMedGoogle Scholar
• 58 Cichewicz R H, Kouzi S A L. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection.  Med Res Rev. 2004;  24 90-114
  CrossrefPubMedGoogle Scholar
• 59 Eiznhamer D A, Xu Z Q. Betulinic acid: a promising anticancer candidate.  IDrugs. 2004;  7 359-373
  PubMedGoogle Scholar
• 60 Bani S, Kaul A, Khan B, Ahmad S F, Suri K A, Gupta B D, Satti N K, Qazi G N. Suppression of T-lymphocyte activity by lupeol isolated from Crataeva religiosa.  Phytother Res. 2006;  20 279-287
  CrossrefPubMedGoogle Scholar
• 61 Kang S Y, Yoon S Y, Roh D H, Jeon M J, Seo H S, Uh D K, Kwon Y B, Kim H W, Han H J, Lee H J, Lee J H. The anti-arthritic effect of ursolic acid on zymosan-induced acute inflammation and adjuvant-induced chronic arthritis models.  J Pharm Pharmacol. 2008;  60 1347-1354
  CrossrefPubMedGoogle Scholar
• 62 Laszczyk M N. Triterpentrockenextrakt aus Birkenkork (Betula alba cortex) [dissertation]. Freiburg; Albert-Ludwigs-University 2007
  PubMedGoogle Scholar
• 63 Yun Y, Han S, Park E, Yim D, Lee S, Lee C K, Cho K, Kim K. Immunomodulatory activity of betulinic acid by producing pro-inflammatory cytokines and activation of macrophages.  Arch Pharm Res. 2003;  26 1087-1095
  CrossrefPubMedGoogle Scholar
• 64 Ikeda Y, Murakami A, Fujimura Y, Tachibana H, Yamada K, Masuda D, Hirano K, Yamashita S, Ohigashi H. Aggregated ursolic acid, a natural triterpenoid, induces IL-1beta release from murine peritoneal macrophages: role of CD36.  J Immunol. 2007;  178 4854-4864
  PubMedGoogle Scholar
• 65 Marquez-Martin A, De La Puerta R, Fernandez-Arche A, Ruiz-Gutierrez V, Yaqoob P. Modulation of cytokine secretion by pentacyclic triterpenes from olive pomace oil in human mononuclear cells.  Cytokine. 2006;  36 211-217
  CrossrefPubMedGoogle Scholar
• 66 Vasconcelos M A, Royo V A, Ferreira D S, Crotti A E, Andrade e Silva M L, Carvalho J C, Bastos J K, Cunha W R. In vivo analgesic and anti-inflammatory activities of ursolic acid and oleanoic acid from Miconia albicans (Melastomataceae).  Z Naturforsch [C]. 2006;  61 477-482
  PubMedGoogle Scholar
• 67 Van Waes C. Nuclear factor-kappaB in development, prevention, and therapy of cancer.  Clin Cancer Res. 2007;  13 1076-1082
  CrossrefPubMedGoogle Scholar
• 68 Takada Y, Aggarwal B B. Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p 65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9.  J Immunol. 2003;  171 3278-3286
  PubMedGoogle Scholar
• 69 Shishodia S, Majumdar S, Banerjee S, Aggarwal B B. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p 65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.  Cancer Res. 2003;  63 4375-4383
  PubMedGoogle Scholar
• 70 You H J, Choi C Y, Kim J Y, Park S J, Hahm K S, Jeong H G. Ursolic acid enhances nitric oxide and tumor necrosis factor-alpha production via nuclear factor-kappaB activation in the resting macrophages.  FEBS Lett. 2001;  509 156-160
  CrossrefPubMedGoogle Scholar
• 71 Choi C Y, You H J, Jeong H G L. Nitric oxide and tumor necrosis factor-alpha production by oleanolic acid via nuclear factor-kappaB activation in macrophages.  Biochem Biophys Res Commun. 2001;  288 49-55
  CrossrefPubMedGoogle Scholar
• 72 Suh N, Honda T, Finlay H J, Barchowsky A, Williams C, Benoit N E, Xie Q W, Nathan C, Gribble G W, Sporn M B. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages.  Cancer Res. 1998;  58 717-723
  PubMedGoogle Scholar
• 73 Bernard P, Scior T, Didier B, Hibert M, Berthon J Y L. Ethnopharmacology and bioinformatic combination for leads discovery: application to phospholipase A(2) inhibitors.  Phytochemistry. 2001;  58 865-874
  CrossrefPubMedGoogle Scholar
• 74 Dharmappa K K, Kumar R V, Nataraju A, Mohamed R, Shivaprasad H V, Vishwanath B S. Anti-inflammatory activity of oleanolic acid by inhibition of secretory phospholipase A2.  Planta Med. 2009;  75 211-215
  Article in Thieme ConnectPubMedGoogle Scholar
• 75 Reyes C P, Nunez M J, Jimenez I A, Busserolles J, Alcaraz M J, Bazzocchi I L. Activity of lupane triterpenoids from Maytenus species as inhibitors of nitric oxide and prostaglandin E2.  Bioorg Med Chem. 2006;  14 1573-1579
  CrossrefPubMedGoogle Scholar
• 76 Saleem M, Afaq F, Adhami V M, Mukhtar H. Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice.  Oncogene. 2004;  23 5203-5214
  CrossrefPubMedGoogle Scholar
• 77 Telliez A, Furman C, Pommery N, Henichart J P. Mechanisms leading to COX-2 expression and COX-2 induced tumorigenesis: topical therapeutic strategies targeting COX-2 expression and activity.  Anticancer Agents Med Chem. 2006;  6 187-208
  CrossrefPubMedGoogle Scholar
• 78 Valko M, Leibfritz D, Moncol J, Cronin M T, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease.  Int J Biochem Cell Biol. 2007;  39 44-84
  CrossrefPubMedGoogle Scholar
• 79 Castelao J E, Gago-Dominguez M. Risk factors for cardiovascular disease in women: relationship to lipid peroxidation and oxidative stress.  Med Hypotheses. 2008;  71 39-44
  CrossrefPubMedGoogle Scholar
• 80 Leitinger N. The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans.  Subcell Biochem. 2008;  49 325-350
  PubMedGoogle Scholar
• 81 Valko M, Rhodes C J, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer.  Chem Biol Interact. 2006;  160 1-40
  CrossrefPubMedGoogle Scholar
• 82 Kalpakcioglu B, Senel K. The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis.  Clin Rheumatol. 2008;  27 141-145
  CrossrefPubMedGoogle Scholar
• 83 Afonso V, Champy R, Mitrovic D, Collin P, Lomri A. Reactive oxygen species and superoxide dismutases: role in joint diseases.  Joint Bone Spine. 2007;  74 324-329
  CrossrefPubMedGoogle Scholar
• 84 Fernandes A P, Holmgren A. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system.  Antioxid Redox Signal. 2004;  6 63-74
  CrossrefPubMedGoogle Scholar
• 85 Prasad S, Kalra N, Singh M, Shukla Y. Protective effects of lupeol and mango extract against androgen induced oxidative stress in Swiss albino mice.  Asian J Androl. 2008;  10 313-318
  CrossrefPubMedGoogle Scholar
• 86 Ramachandran S, Prasad N R. Effect of ursolic acid, a triterpenoid antioxidant, on ultraviolet-B radiation-induced cytotoxicity, lipid peroxidation and DNA damage in human lymphocytes.  Chem Biol Interact. 2008;  176 99-107
  CrossrefPubMedGoogle Scholar
• 87 Sudhahar V, Ashok Kumar S, Varalakshmi P, Sujatha V. Protective effect of lupeol and lupeol linoleate in hypercholesterolemia associated renal damage.  Mol Cell Biochem. 2008;  317 11-20
  CrossrefPubMedGoogle Scholar
• 88 Sudharsan P T, Mythili Y, Selvakumar E, Varalakshmi P. Cardioprotective effect of pentacyclic triterpene, lupeol and its ester on cyclophosphamide-induced oxidative stress.  Hum Exp Toxicol. 2005;  24 313-318
  CrossrefPubMedGoogle Scholar
• 89 Sultana S, Saleem M, Sharma S, Khan N. Lupeol, a triterpene, prevents free radical mediated macromolecular damage and alleviates benzoyl peroxide induced biochemical alterations in murine skin.  Indian J Exp Biol. 2003;  41 827-831
  PubMedGoogle Scholar
• 90 Malini M M, Lenin M, Varalakshmi P. Protective effect of triterpenes on calcium oxalate crystal-induced peroxidative changes in experimental urolithiasis.  Pharmacol Res. 2000;  41 413-418
  CrossrefPubMedGoogle Scholar
• 91 Geetha T, Varalakshmi P. Anticomplement activity of triterpenes from Crataeva nurvala stem bark in adjuvant arthritis in rats.  Gen Pharmacol. 1999;  32 495-497
  CrossrefPubMedGoogle Scholar
• 92 Vidya L, Malini M M, Varalakshmi P. Effect of pentacyclic triterpenes on oxalate-induced changes in rat erythrocytes.  Pharmacol Res. 2000;  42 313-316
  CrossrefPubMedGoogle Scholar
• 93 Geetha T, Varalakshmi P, Latha R M. Effect of triterpenes from Crataeva nurvala stem bark on lipid peroxidation in adjuvant induced arthritis in rats.  Pharmacol Res. 1998;  37 191-195
  CrossrefPubMedGoogle Scholar
• 94 Vidya L, Varalakshmi P. Control of urinary risk factors of stones by betulin and lupeol in experimental hyperoxaluria.  Fitoterapia. 2000;  71 535-543
  CrossrefPubMedGoogle Scholar
• 95 Sudhahar V, Ashokkumar S, Varalakshmi P. Effect of lupeol and lupeol linoleate on lipemic – hepatocellular aberrations in rats fed a high cholesterol diet.  Mol Nutr Food Res. 2006;  50 1212-1219
  CrossrefPubMedGoogle Scholar
• 96 Sudhahar V, Kumar S A, Sudharsan P T, Varalakshmi P. Protective effect of lupeol and its ester on cardiac abnormalities in experimental hypercholesterolemia.  Vasc Pharmacol. 2007;  46 412-418
  CrossrefPubMedGoogle Scholar
• 97 Prasad S, Kalra N, Shukla Y. Hepatoprotective effects of lupeol and mango pulp extract of carcinogen induced alteration in Swiss albino mice.  Mol Nutr Food Res. 2007;  51 352-359
  CrossrefPubMedGoogle Scholar
• 98 Preetha S P, Kanniappan M, Selvakumar E, Nagaraj M, Varalakshmi P. Lupeol ameliorates aflatoxin B1-induced peroxidative hepatic damage in rats.  Comp Biochem Physiol C Toxicol Pharmacol. 2006;  143 333-339
  CrossrefPubMedGoogle Scholar
• 99 Nagaraj M, Sunitha S, Varalakshmi P. Effect of lupeol, a pentacyclic triterpene, on the lipid peroxidation and antioxidant status in rat kidney after chronic cadmium exposure.  J Appl Toxicol. 2000;  20 413-417
  CrossrefPubMedGoogle Scholar
• 100 Sunitha S, Nagaraj M, Varalakshmi P. Hepatoprotective effect of lupeol and lupeol linoleate on tissue antioxidant defence system in cadmium-induced hepatotoxicity in rats.  Fitoterapia. 2001;  72 516-523
  CrossrefPubMedGoogle Scholar
• 101 Saleem M, Alam A, Arifin S, Shah M S, Ahmed B, Sultana S. Lupeol, a triterpene, inhibits early responses of tumor promotion induced by benzoyl peroxide in murine skin.  Pharmacol Res. 2001;  43 127-134
  CrossrefPubMedGoogle Scholar
• 102 Nigam N, Prasad S, Shukla Y. Preventive effects of lupeol on DMBA induced DNA alkylation damage in mouse skin.  Food Chem Toxicol. 2007;  45 2331-2335
  PubMedGoogle Scholar
• 103 Miura N, Matsumoto Y, Miyairi S, Nishiyama S, Naganuma A. Protective effects of triterpene compounds against the cytotoxicity of cadmium in HepG2 cells.  Mol Pharmacol. 1999;  56 1324-1328
  PubMedGoogle Scholar
• 104 Szuster-Ciesielska A, Kandefer-Szerszen M. Protective effects of betulin and betulinic acid against ethanol-induced cytotoxicity in HepG2 cells.  Pharmacol Rep. 2005;  57 588-595
  PubMedGoogle Scholar
• 105 Furtado R A, Rodrigues E P, Araujo F R, Oliveira W L, Furtado M A, Castro M B, Cunha W R, Tavares D C. Ursolic acid and oleanolic acid suppress preneoplastic lesions induced by 1, 2-dimethylhydrazine in rat colon.  Toxicol Pathol. 2008;  36 576-580
  CrossrefPubMedGoogle Scholar
• 106 Liu J, Wu Q, Lu Y F, Pi J. New insights into generalized hepatoprotective effects of oleanolic acid: key roles of metallothionein and Nrf2 induction.  Biochem Pharmacol. 2008;  76 922-928
  CrossrefPubMedGoogle Scholar
• 107 Eggler A L, Gay K A, Mesecar A D. Molecular mechanisms of natural products in chemoprevention: induction of cytoprotective enzymes by Nrf2.  Mol Nutr Food Res. 2008;  52 (Suppl. 1) S84-S94
  PubMedGoogle Scholar
• 108 Lee K H, Nam G W, Kim S H, Lee S H. Phytocomponents of triterpenoids, oleanolic acid and ursolic acid, regulated differently the progressing of epidermal keratinocytes via PPAR-a pathway.  Exp Dermatol. 2006;  15 66-73
  CrossrefPubMedGoogle Scholar
• 109 Woelfle U L M, Kraus M, Leuner K, Kersten A, Simon-Haarhaus B, Scheffler A, Martin S F, Müller W E, Nashan D, Schempp C M. Triterpenes promote keratinocyte differentiation in vitro, ex vivo and in vivo. A role for the transient receptor potential canonical (subtype) 6.  JID. 2009;  DOI: 10.1038/jid.2009.248
  PubMedGoogle Scholar
• 110 Schmuth M, Jiang Y J, Dubrac S, Elias P M, Feingold K R. Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology.  J Lipid Res. 2008;  49 499-509
  CrossrefPubMedGoogle Scholar
• 111 Lim S W, Hong S P, Jeong S W, Kim B, Bak H, Ryoo H C, Lee S H, Ahn S K. Simultaneous effect of ursolic acid and oleanolic acid on epidermal permeability barrier function and epidermal keratinocyte differentiation via peroxisome proliferator-activated receptor-alpha.  J Dermatol. 2007;  34 625-634
  CrossrefPubMedGoogle Scholar
• 112 Muller M, Essin K, Hill K, Beschmann H, Rubant S, Schempp C M, Gollasch M, Boehncke W H, Harteneck C, Muller W E, Leuner K. Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiation.  J Biol Chem. 2008;  283 33942-33954
  CrossrefPubMedGoogle Scholar
• 113 Lee H Y, Chung H Y, Kim K H, Lee J J, Kim K W. Induction of differentiation in the cultured F9 teratocarcinoma stem cells by triterpene acids.  J Cancer Res Clin Oncol. 1994;  120 513-518
  CrossrefPubMedGoogle Scholar
• 114 Paik K J, Jeon S S, Chung H Y, Lee K H, Kim K W, Chung J K, Kim N D. Induction of differentiation of the cultured rat mammary epithelial cells by triterpene acids.  Arch Pharm Res. 1998;  21 398-405
  PubMedGoogle Scholar
• 115 Hata K, Hori K, Murata J, Takahashi S. Remodeling of actin cytoskeleton in lupeol-induced B16 2F2 cell differentiation.  J Biochem. 2005;  138 467-472
  CrossrefPubMedGoogle Scholar
• 116 Ogiwara K, Hata K. Melanoma cell differentiation induced by lupeol separates into two stages: morphological and functional changes.  Nat Med (Tokyo). 2009;  63 323-326
  PubMedGoogle Scholar
• 117 Poon K H, Zhang J, Wang C, Tse A K, Wan C K, Fong W F. Betulinic acid enhances 1alpha,25-dihydroxyvitamin D3-induced differentiation in human HL-60 promyelocytic leukemia cells.  Anticancer Drugs. 2004;  15 619-624
  CrossrefPubMedGoogle Scholar
• 118 Hata K, Hori K, Takahashi S. Differentiation- and apoptosis-inducing activities by pentacyclic triterpenes on a mouse melanoma cell line.  J Nat Prod. 2002;  65 645-648
  CrossrefPubMedGoogle Scholar
• 119 Pisha E, Chai H, Lee I S, Chagwedera T E, Farnsworth N R, Cordell G A, Beecher C W, Fong H H, Kinghorn A D, Brown D M, Wani M C, Wall M E, Hieken T J, Das Gupta T K, Pezzuto J M. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis.  Nat Med. 1995;  1 1046-1051
  CrossrefPubMedGoogle Scholar
• 120 Udeani G O, Zhao G M, Geun Shin Y, Cooke B P, Graham J, Beecher C W, Kinghorn A D, Pezzuto J M. Pharmacokinetics and tissue distribution of betulinic acid in CD-1 mice.  Biopharm Drug Dispos. 1999;  20 379-383
  CrossrefPubMedGoogle Scholar
• 121 Jäger S, Laszczyk M N, Scheffler A. A preliminary pharmacokinetic study of betulin, the main pentacyclic triterpene from extract of outer bark of birch (Betulae alba cortex).  Molecules. 2008;  13 3224-3235
  CrossrefPubMedGoogle Scholar
• 122 Jäger S, Winkler K, Pfüller U, Scheffler A. Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album L.  Planta Med. 2007;  73 157-162
  Article in Thieme ConnectPubMedGoogle Scholar
• 123 Prasad S, Kalra N, Shukla Y. Induction of apoptosis by lupeol and mango extract in mouse prostate and LNCaP cells.  Nutr Cancer. 2008;  60 120-130
  PubMedGoogle Scholar
• 124 Saleem M, Maddodi N, Abu Zaid M, Khan N, bin Hafeez B, Asim M, Suh Y, Yun J M, Setaluri V, Mukhtar H. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis.  Clin Cancer Res. 2008;  14 2119-2127
  CrossrefPubMedGoogle Scholar
• 125 Raphael T J, Kuttan G. Effect of naturally occurring triterpenoids ursolic acid and glycyrrhizic acid on the cell-mediated immune responses of metastatic tumor-bearing animals.  Immunopharmacol Immunotoxicol. 2008;  30 243-255
  CrossrefPubMedGoogle Scholar
• 126 Lee I, Lee J, Lee Y H, Leonard J. Ursolic acid-induced changes in tumor growth, O2 consumption, and tumor interstitial fluid pressure.  Anticancer Res. 2001;  21 2827-2833
  PubMedGoogle Scholar
• 127 Sawada N, Kataoka K, Kondo K, Arimochi H, Fujino H, Takahashi Y, Miyoshi T, Kuwahara T, Monden Y, Ohnishi Y. Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice.  Br J Cancer. 2004;  90 1672-1678
  CrossrefPubMedGoogle Scholar
• 128 Lee T K, Poon R T, Wo J Y, Ma S, Guan X Y, Myers J N, Altevogt P, Yuen A P. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.  Cancer Res. 2007;  67 8800-8809
  CrossrefPubMedGoogle Scholar
• 129 Liu J. Pharmacology of oleanolic acid and ursolic acid.  J Ethnopharmacol. 1995;  49 57-68
  CrossrefPubMedGoogle Scholar
• 130 Singh G B, Singh S, Bani S, Gupta B D, Banerjee S K. Anti-inflammatory activity of oleanolic acid in rats and mice.  J Pharm Pharmacol. 1992;  44 456-458
  PubMedGoogle Scholar
• 131 Shin Y G, Cho K H, Chung S M, Graham J, Das Gupta T K, Pezzuto J M. Determination of betulinic acid in mouse blood, tumor and tissue homogenates by liquid chromatography-electrospray mass spectrometry.  J Chromatogr B Biomed Sci Appl. 1999;  732 331-336
  CrossrefPubMedGoogle Scholar
• 132 Guo M, Zhang S, Song F, Wang D, Liu Z, Liu S. Studies on the non-covalent complexes between oleanolic acid and cyclodextrins using electrospray ionization tandem mass spectrometry.  J Mass Spectrom. 2003;  38 723-731
  CrossrefPubMedGoogle Scholar
• 133 Strüh C, Jäger S, Schempp C M, Scheffler A, Martin S F. Solubilized triterpenes from mistletoe show anti-tumor effects on skin-derived cell lines.  Planta Med. 2008;  74 1130
  PubMedGoogle Scholar
• 134 Kang H S, Park J E, Lee Y J, Chang I S, Chung Y I, Tae G. Preparation of liposomes containing oleanolic acid via micelle-to-vesicle transition.  J Nanosci Nanotechnol. 2007;  7 3944-3948
  CrossrefPubMedGoogle Scholar

Dr. Melanie N. Laszczyk

Betulin-Institut

Blumenstr. 25

64297 Darmstadt

Germany

Phone: + 49 72 33 82 93 71

Email: m.laszczyk@betulin-institut.de